Large-scale testing (Phase 3)Looking for participantsNCT07204457
What this trial is testing
Immunogenicity and Safety of Meningococcal Conjugate Vaccine (EG-MCV4) in Healthy Adults Aged 19 to 55 Years Old
Who this might be right for
Meningococcal Infections
EyeGene Inc. 1,123